Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

M Karbiener; G Kindle; I Meyts; MRJ Seppänen; Fabio Candotti; M Kamieniak; R Ilk; TR Kreil; MG Seidel; ESID-COVID Consortium

doi:10.1002/jmv.29738

Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

M Karbiener
, G Kindle
, I Meyts
, MRJ Seppänen
, Fabio Candotti
, M Kamieniak
, R Ilk
, TR Kreil
, MG Seidel
, ESID-COVID Consortium

Department of Pediatrics and Adolescent Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e29738
Number of pages	1
Journal	Journal of Medical Virology
Volume	96
Issue number	6
DOIs	https://doi.org/10.1002/jmv.29738
Publication status	Published - Jun 2024

Fields of science

302035 Paediatrics and adolescent medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/jmv.29738

Cite this

Karbiener, M., Kindle, G., Meyts, I., Seppänen, MRJ., Candotti, F., Kamieniak, M., Ilk, R., Kreil, TR., Seidel, MG., & ESID-COVID Consortium (2024). Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency. Journal of Medical Virology, 96(6), Article e29738. https://doi.org/10.1002/jmv.29738

@article{ddf31a13ceac451bbaac8ebccd612e4e,

title = "Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency",

author = "M Karbiener and G Kindle and I Meyts and MRJ Sepp{\"a}nen and Fabio Candotti and M Kamieniak and R Ilk and TR Kreil and MG Seidel and \{ESID-COVID Consortium\}",

year = "2024",

month = jun,

doi = "10.1002/jmv.29738",

language = "English",

volume = "96",

journal = "Journal of Medical Virology",

issn = "0146-6615",

number = "6",

}

Karbiener, M, Kindle, G, Meyts, I, Seppänen, MRJ, Candotti, F, Kamieniak, M, Ilk, R, Kreil, TR, Seidel, MG & ESID-COVID Consortium 2024, 'Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency', Journal of Medical Virology, vol. 96, no. 6, e29738. https://doi.org/10.1002/jmv.29738

TY - JOUR

T1 - Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

AU - Karbiener, M

AU - Kindle, G

AU - Meyts, I

AU - Seppänen, MRJ

AU - Candotti, Fabio

AU - Kamieniak, M

AU - Ilk, R

AU - Kreil, TR

AU - Seidel, MG

AU - ESID-COVID Consortium, null

PY - 2024/6

Y1 - 2024/6

UR - https://www.scopus.com/pages/publications/85196384619

U2 - 10.1002/jmv.29738

DO - 10.1002/jmv.29738

M3 - Article

SN - 0146-6615

VL - 96

JO - Journal of Medical Virology

JF - Journal of Medical Virology

IS - 6

M1 - e29738

ER -

Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this